Value Sense
CVS
CVS Health Corporation (CVS)
Last Price$64.9(1.2%)
Market Cap$82.3B
EV/EBIT LTM
13.5x
5Y avg
14.9x
Medical - Healthcare Plans industry median
9.3x
Stock quality & Intrinsic value
5/10
2.2% undervalued
CVS
is 220.8% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

CVS Health Corporation EV/EBIT LTM

Annual
Quarterly
Daily
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
EV/EBIT LTM
13.6x
13.8x
16.2x
8.5x
9.0x
9.2x
10.1x
9.9x
11.6x
14.0x
14.8x
10.7x
10.3x
14.9x
17.4x
11.4x
15.0x
26.5x
11.8x
13.5x
CVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CVS and see if it's the right time to invest.
Dive in

CVS Health Corporation (CVS) EV/EBIT LTM comparison analysis

General

LTM EV/EBIT LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

CVS Health Corporation logo
CVS Health CorporationCVS
18.1x
4.2%
(43.6%)
1.2%
Median Peer Set
9.3x
8.9%
(4.8%)
2.0%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
32.3x
56.5%
N/A
0.3%
Cigna Corporation logo
Cigna CorporationCI
17.3x
8.4%
(18.9%)
2.6%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
12.7x
8.9%
(35.7%)
3.6%
Centene Corporation logo
Centene CorporationCNC
9.7x
5.9%
27.4%
2.0%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
9.3x
19.3%
9.2%
2.9%
Humana Inc. logo
Humana Inc.HUM
7.4x
10.7%
(50.1%)
1.0%
Elevance Health Inc. logo
Elevance Health Inc.ELV
2.0x
3.2%
(0.0%)
3.4%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
(26.4x)
27.2%
(4.8%)
(8.1%)
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
(36.1x)
(41.5%)
(31.3%)
(10.5%)

CVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
37,006.7
21.0%
43,821.4
18.4%
76,329.5
74.2%
87,472.0
14.6%
98,215.0
12.3%
95,778.0
(2.5%)
107,080.0
11.8%
123,120.0
15.0%
126,761.0
3.0%
139,367.0
9.9%
153,290.0
10.0%
177,546.0
15.8%
184,786.0
4.1%
194,579.0
5.3%
256,776.0
32.0%
268,706.0
4.6%
292,111.0
8.7%
322,467.0
10.4%
357,776.0
10.9%
372,809.0
4.2%
Cost of Goods Sold (COGS)27,312.132,079.260,221.869,182.077,857.075,559.086,518.0100,632.0102,978.0114,000.0126,762.0148,712.0156,258.0163,041.0211,248.0219,660.0239,991.0267,965.0303,345.0321,408.0
Gross Profit
% margin
9,694.6
26.2%
11,742.2
26.8%
16,107.7
21.1%
18,290.0
20.9%
20,358.0
20.7%
20,219.0
21.1%
20,562.0
19.2%
22,488.0
18.3%
23,783.0
18.8%
25,367.0
18.2%
26,528.0
17.3%
28,834.0
16.2%
28,528.0
15.4%
31,538.0
16.2%
45,528.0
17.7%
49,046.0
18.3%
52,120.0
17.8%
54,502.0
16.9%
54,431.0
15.2%
51,401.0
13.8%
Operating Expenses7,675.19,300.611,314.412,244.013,933.014,082.014,231.015,278.015,746.016,568.017,053.018,448.018,990.027,517.033,541.035,135.038,810.046,548.040,688.041,606.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)7,675.19,300.611,314.412,244.213,933.014,092.014,231.00.00.00.00.00.00.00.00.00.00.00.00.0(1,279.0)
Operating Income
% margin
2,019.5
5.5%
2,441.6
5.6%
4,793.3
6.3%
6,046.0
6.9%
6,425.0
6.5%
6,137.0
6.4%
6,331.0
5.9%
7,210.0
5.9%
8,037.0
6.3%
8,799.0
6.3%
9,475.0
6.2%
10,386.0
5.8%
9,538.0
5.2%
4,021.0
2.1%
11,987.0
4.7%
13,911.0
5.2%
13,310.0
4.6%
7,954.0
2.5%
13,743.0
3.8%
8,516.0
2.3%
Interest Income0.00.00.021.05.03.04.04.08.015.021.020.021.00.00.00.00.00.00.00.0
Interest Expense0.00.00.0530.0530.0539.0588.0561.0517.0615.0859.01,078.01,062.02,619.03,035.02,907.02,503.02,287.02,658.02,958.0
Pre-tax Income1,909.02,225.84,358.75,537.05,900.05,601.05,747.06,305.07,528.07,678.08,616.08,637.08,268.01,406.08,997.09,770.010,537.05,836.011,173.06,148.0
Income Tax
% effective tax rate
684.3
35.8%
856.9
38.5%
1,721.7
39.5%
2,193.0
39.6%
2,200.0
37.3%
2,179.0
38.9%
2,258.0
39.3%
2,436.0
38.6%
2,928.0
38.9%
3,033.0
39.5%
3,386.0
39.3%
3,317.0
38.4%
1,637.0
19.8%
2,002.0
142.4%
2,366.0
26.3%
2,569.0
26.3%
2,548.0
24.2%
1,509.0
25.9%
2,805.0
25.1%
1,562.0
25.4%
Net Income
% margin
1,224.7
3.3%
1,368.9
3.1%
2,637.0
3.5%
3,212.0
3.7%
3,696.0
3.8%
3,427.0
3.6%
3,462.0
3.2%
3,864.0
3.1%
4,592.0
3.6%
4,644.0
3.3%
5,237.0
3.4%
5,317.0
3.0%
6,622.0
3.6%
(594.0)
(0.3%)
6,634.0
2.6%
7,179.0
2.7%
8,001.0
2.7%
4,311.0
1.3%
8,344.0
2.3%
4,614.0
1.2%
EPS1.491.651.972.232.582.512.593.053.773.984.664.936.47(0.57)5.105.486.003.296.493.66
Diluted EPS1.451.601.922.182.552.492.573.033.743.964.634.906.44(0.57)5.085.465.953.266.473.66
EBITDA
% margin
2,608.6
7.0%
3,174.9
7.2%
5,887.9
7.7%
7,341.0
8.4%
7,819.0
8.0%
7,609.0
7.9%
7,903.0
7.4%
8,619.0
7.0%
9,915.0
7.8%
10,224.0
7.3%
11,567.0
7.5%
12,190.0
6.9%
11,809.0
6.4%
6,743.0
3.5%
16,403.0
6.4%
17,118.0
6.4%
17,526.0
6.0%
12,347.0
3.8%
18,197.0
5.1%
13,703.0
3.7%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is CVS Health Corporation's EV/EBIT LTM?

As of today, Microsoft Corp's last 12-month EV/EBIT LTM is 13.5x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual EV/EBIT LTM for CVS Health Corporation have been 15.6x over the past three years, and 15.6x over the past five years.

2) Is CVS Health Corporation's EV/EBIT LTM Good?

As of today, CVS Health Corporation's EV/EBIT LTM is 13.5x, which is higher than industry median of 9.3x. It indicates that CVS Health Corporation's EV/EBIT LTM is Bad.

3) How does CVS Health Corporation's EV/EBIT LTM compare to its peers?

As of today, CVS Health Corporation's EV/EBIT LTM is 13.5x, which is higher than peer median of 9.3x. The list of peers includes OSCR, CI, UNH, CNC, MOH, HUM, ELV, ALHC, CLOV.